Diabetic Neuropathy Study Group: Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study (vol 24, pg 1776, 2001)

被引：0
|
作者：
Hotta, N
Toyota, T
Matsuoka, K
Shigeta, Y
Kikkawa, R
Kaneko, T
Takahashi, A
Sugimura, K
Koike, Y
Ishii, J
Sakamoto, N
机构：
来源：
DIABETES CARE | 2002年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
    Joseph C Arezzo
    Julio Rosenstock
    Linda LaMoreaux
    Lynne Pauer
    BMC Neurology, 8
  • [32] Topical Ketamine Cream in the Treatment of Painful Diabetic Neuropathy A Randomized, Placebo-controlled, Double-blind Initial Study
    Mahoney, James M.
    Vardaxis, Vassilios
    Moore, Joshua L.
    Hall, Andrew M.
    Haffner, Kyle E.
    Peterson, Matthew C.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2012, 102 (03) : 178 - 183
  • [33] Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study
    Cao, Kegang
    Yu, Lihua
    Gao, Ying
    Fan, Yongping
    Zhao, Jianjun
    Zhang, Xuezhi
    Xie, Wei
    Yang, Wenming
    Dong, Mengjiu
    Li, Tao
    Qiao, Xiangyang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (03) : 259 - 267
  • [34] Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
    Lowe, Nicholas J.
    Glaser, Dee Anna
    Eadie, Nina
    Daggett, Simon
    Kowalski, Jonathan W.
    Lai, Pan-Yu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 604 - 611
  • [35] LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy-Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study
    Busui, Rodica
    Patel, Anand
    Sang, Christine N.
    Granowitz, Craig B.
    Banks, Phillip L.
    Pierce, Phillip
    Sun, Franklin W.
    Gopinathan, Suma
    DIABETES, 2023, 72
  • [36] Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan
    Sekiguchi, Kenji
    Kohara, Nobuo
    Baba, Masayuki
    Komori, Tetsuo
    Naito, Yutaka
    Imai, Tomihiro
    Satoh, Jo
    Yamaguchi, Yasuyuki
    Hamatani, Tatsuto
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 466 - 474
  • [37] Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Kane, John M.
    Sanchez, Raymond
    Perry, Pamela P.
    Jin, Na
    Johnson, Brian R.
    Forbes, Robert A.
    McQuade, Robert D.
    Carson, William H.
    Fleischhacker, W. Wolfgang
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (05) : 617 - 624
  • [38] Efficacy of vitamin D2 on severe diabetic peripheral neuropathy of type 2 diabetes mellitus: a multicenter random double-blind, placebo-controlled trial
    Zheng, Yueyue
    Liu, Dexue
    Shi, Xiaoxia
    Xu, Na
    Li, Ruige
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [39] Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks:: a double-blind, placebo-controlled parallel group multicenter study
    Leinisch, E
    Evers, S
    Kaempfe, N
    Kraemer, C
    Sostak, P
    Jürgens, T
    Straube, A
    May, A
    PAIN, 2005, 117 (03) : 396 - 400
  • [40] Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study
    Agrawal, R. P.
    Goswami, Jitender
    Jain, Shreyans
    Kochar, D. K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (03) : 371 - 378
12345